Loading…

A feline model of spontaneously occurring autoimmune limbic encephalitis

Autoimmune encephalitis (AE) is an important cause of encephalitis in humans and occurs at a similar rate to infectious encephalitis. It is frequently associated with antibodies against the extracellular domain of neuronal proteins. Among human AE, that with antibodies against leucine-rich glioma-in...

Full description

Saved in:
Bibliographic Details
Published in:The veterinary journal (1997) 2023-06, Vol.296-297, p.105974-105974, Article 105974
Main Authors: Glantschnigg-Eisl, U., Klang, A., Kneissl, S., Lang, B., Waters, P., Irani, S.R., Binks, S.N.M., Pakozdy, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c351t-7a3b5bd2e00fffd51731633a3726d270557d796e034fde570420a30a140ccbcb3
container_end_page 105974
container_issue
container_start_page 105974
container_title The veterinary journal (1997)
container_volume 296-297
creator Glantschnigg-Eisl, U.
Klang, A.
Kneissl, S.
Lang, B.
Waters, P.
Irani, S.R.
Binks, S.N.M.
Pakozdy, A.
description Autoimmune encephalitis (AE) is an important cause of encephalitis in humans and occurs at a similar rate to infectious encephalitis. It is frequently associated with antibodies against the extracellular domain of neuronal proteins. Among human AE, that with antibodies against leucine-rich glioma-inactivated 1 (LGI1) is one of the most prevalent forms, and was recently described in cats with limbic encephalitis (LE). In this study, we describe a large cohort (n = 32) of cats with AE, tested positive for voltage gated potassium channel (VGKC)-antibodies, of which 26 (81%) harboured LGI1-antibodies. We delineate their clinical and paraclinical features as well as long-term outcomes up to 5 years. Similar to human cases, most cats with LGI1-antibodies had a history of focal seizures (83%), clustering in the majority (88%), with interictal behavioural changes (73%). Among feline AE patients, there was no seizure type or other clinical characteristic that could distinguish LGI1-antibody positive from negative cats, unlike the pathognomic faciobrachial dystonic seizures seen in humans. Although six cats were euthanased in the first year for epilepsy-associated reasons, those attaining at least 1-year survival had good seizure control and quality of life with appropriate veterinary care and medication. Acute-phase immunotherapy (prednisolone) was given to the most severely unwell cases and its effect is retrospectively evaluated in 10 cats. Our data show LGI1-antibodies are an important cause of feline encephalitis, sharing many features with human AE. Further research should examine optimal therapeutic management strategies and the cause of LE in seronegative cats, building on paradigms established in the counterpart human disease. •Antibodies against leucine-rich glioma-inactivated 1 (LGI1) were studied.•They were associated with epileptic seizures and limbic encephalitis (LE) in cats.•Feline LE presented with focal seizures, often clustering, and behavioural changes.•Blood and cerebrospinal fluid analysis and brain imaging was often unremarkable.•Some cats were refractory to treatment but others attained good long-term outcomes.
doi_str_mv 10.1016/j.tvjl.2023.105974
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2791373551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1090023323000254</els_id><sourcerecordid>2791373551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-7a3b5bd2e00fffd51731633a3726d270557d796e034fde570420a30a140ccbcb3</originalsourceid><addsrcrecordid>eNp9kEFLwzAYhoMoTqd_wIP06KXzS9I0FrwMUScMvOg5pMlXzUibmbQD_70dnR49JSTP-_J9DyFXFBYUaHm7WfS7jV8wYHx8EJUsjsgZFZzlrJL0eLxDBfn4y2fkPKUNAFRFwU7JjJeVuCtAnJHVMmvQuw6zNlj0WWiytA1drzsMQ_LfWTBmiNF1H5ke-uDadhhZ79ramQw7g9tP7V3v0gU5abRPeHk45-T96fHtYZWvX59fHpbr3HBB-1xqXovaMgRomsYKKjktOddcstIyCUJIK6sSgReNRSGhYKA5aFqAMbWp-ZzcTL3bGL4GTL1qXTLo_TSxYrKiXHIh6IiyCTUxpBSxUdvoWh2_FQW1N6g2am9Q7Q2qyeAYuj70D3WL9i_yq2wE7icAxy13DqNKxu1NWBfR9MoG91__D2mUghg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791373551</pqid></control><display><type>article</type><title>A feline model of spontaneously occurring autoimmune limbic encephalitis</title><source>ScienceDirect Freedom Collection</source><creator>Glantschnigg-Eisl, U. ; Klang, A. ; Kneissl, S. ; Lang, B. ; Waters, P. ; Irani, S.R. ; Binks, S.N.M. ; Pakozdy, A.</creator><creatorcontrib>Glantschnigg-Eisl, U. ; Klang, A. ; Kneissl, S. ; Lang, B. ; Waters, P. ; Irani, S.R. ; Binks, S.N.M. ; Pakozdy, A.</creatorcontrib><description>Autoimmune encephalitis (AE) is an important cause of encephalitis in humans and occurs at a similar rate to infectious encephalitis. It is frequently associated with antibodies against the extracellular domain of neuronal proteins. Among human AE, that with antibodies against leucine-rich glioma-inactivated 1 (LGI1) is one of the most prevalent forms, and was recently described in cats with limbic encephalitis (LE). In this study, we describe a large cohort (n = 32) of cats with AE, tested positive for voltage gated potassium channel (VGKC)-antibodies, of which 26 (81%) harboured LGI1-antibodies. We delineate their clinical and paraclinical features as well as long-term outcomes up to 5 years. Similar to human cases, most cats with LGI1-antibodies had a history of focal seizures (83%), clustering in the majority (88%), with interictal behavioural changes (73%). Among feline AE patients, there was no seizure type or other clinical characteristic that could distinguish LGI1-antibody positive from negative cats, unlike the pathognomic faciobrachial dystonic seizures seen in humans. Although six cats were euthanased in the first year for epilepsy-associated reasons, those attaining at least 1-year survival had good seizure control and quality of life with appropriate veterinary care and medication. Acute-phase immunotherapy (prednisolone) was given to the most severely unwell cases and its effect is retrospectively evaluated in 10 cats. Our data show LGI1-antibodies are an important cause of feline encephalitis, sharing many features with human AE. Further research should examine optimal therapeutic management strategies and the cause of LE in seronegative cats, building on paradigms established in the counterpart human disease. •Antibodies against leucine-rich glioma-inactivated 1 (LGI1) were studied.•They were associated with epileptic seizures and limbic encephalitis (LE) in cats.•Feline LE presented with focal seizures, often clustering, and behavioural changes.•Blood and cerebrospinal fluid analysis and brain imaging was often unremarkable.•Some cats were refractory to treatment but others attained good long-term outcomes.</description><identifier>ISSN: 1090-0233</identifier><identifier>EISSN: 1532-2971</identifier><identifier>DOI: 10.1016/j.tvjl.2023.105974</identifier><identifier>PMID: 36958405</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Antibodies ; Autoantibodies - therapeutic use ; Autoimmune ; Cat Diseases ; Cats ; Encephalitis ; Encephalitis - complications ; Encephalitis - veterinary ; Humans ; Leucine-rich glioma-inactivated 1 (LGI1) ; Limbic Encephalitis - complications ; Limbic Encephalitis - therapy ; Limbic Encephalitis - veterinary ; Quality of Life ; Retrospective Studies ; Seizures - drug therapy ; Seizures - etiology ; Seizures - veterinary ; Voltage-gated potassium channel (VGKC)</subject><ispartof>The veterinary journal (1997), 2023-06, Vol.296-297, p.105974-105974, Article 105974</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c351t-7a3b5bd2e00fffd51731633a3726d270557d796e034fde570420a30a140ccbcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36958405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glantschnigg-Eisl, U.</creatorcontrib><creatorcontrib>Klang, A.</creatorcontrib><creatorcontrib>Kneissl, S.</creatorcontrib><creatorcontrib>Lang, B.</creatorcontrib><creatorcontrib>Waters, P.</creatorcontrib><creatorcontrib>Irani, S.R.</creatorcontrib><creatorcontrib>Binks, S.N.M.</creatorcontrib><creatorcontrib>Pakozdy, A.</creatorcontrib><title>A feline model of spontaneously occurring autoimmune limbic encephalitis</title><title>The veterinary journal (1997)</title><addtitle>Vet J</addtitle><description>Autoimmune encephalitis (AE) is an important cause of encephalitis in humans and occurs at a similar rate to infectious encephalitis. It is frequently associated with antibodies against the extracellular domain of neuronal proteins. Among human AE, that with antibodies against leucine-rich glioma-inactivated 1 (LGI1) is one of the most prevalent forms, and was recently described in cats with limbic encephalitis (LE). In this study, we describe a large cohort (n = 32) of cats with AE, tested positive for voltage gated potassium channel (VGKC)-antibodies, of which 26 (81%) harboured LGI1-antibodies. We delineate their clinical and paraclinical features as well as long-term outcomes up to 5 years. Similar to human cases, most cats with LGI1-antibodies had a history of focal seizures (83%), clustering in the majority (88%), with interictal behavioural changes (73%). Among feline AE patients, there was no seizure type or other clinical characteristic that could distinguish LGI1-antibody positive from negative cats, unlike the pathognomic faciobrachial dystonic seizures seen in humans. Although six cats were euthanased in the first year for epilepsy-associated reasons, those attaining at least 1-year survival had good seizure control and quality of life with appropriate veterinary care and medication. Acute-phase immunotherapy (prednisolone) was given to the most severely unwell cases and its effect is retrospectively evaluated in 10 cats. Our data show LGI1-antibodies are an important cause of feline encephalitis, sharing many features with human AE. Further research should examine optimal therapeutic management strategies and the cause of LE in seronegative cats, building on paradigms established in the counterpart human disease. •Antibodies against leucine-rich glioma-inactivated 1 (LGI1) were studied.•They were associated with epileptic seizures and limbic encephalitis (LE) in cats.•Feline LE presented with focal seizures, often clustering, and behavioural changes.•Blood and cerebrospinal fluid analysis and brain imaging was often unremarkable.•Some cats were refractory to treatment but others attained good long-term outcomes.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Autoantibodies - therapeutic use</subject><subject>Autoimmune</subject><subject>Cat Diseases</subject><subject>Cats</subject><subject>Encephalitis</subject><subject>Encephalitis - complications</subject><subject>Encephalitis - veterinary</subject><subject>Humans</subject><subject>Leucine-rich glioma-inactivated 1 (LGI1)</subject><subject>Limbic Encephalitis - complications</subject><subject>Limbic Encephalitis - therapy</subject><subject>Limbic Encephalitis - veterinary</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Seizures - drug therapy</subject><subject>Seizures - etiology</subject><subject>Seizures - veterinary</subject><subject>Voltage-gated potassium channel (VGKC)</subject><issn>1090-0233</issn><issn>1532-2971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAYhoMoTqd_wIP06KXzS9I0FrwMUScMvOg5pMlXzUibmbQD_70dnR49JSTP-_J9DyFXFBYUaHm7WfS7jV8wYHx8EJUsjsgZFZzlrJL0eLxDBfn4y2fkPKUNAFRFwU7JjJeVuCtAnJHVMmvQuw6zNlj0WWiytA1drzsMQ_LfWTBmiNF1H5ke-uDadhhZ79ramQw7g9tP7V3v0gU5abRPeHk45-T96fHtYZWvX59fHpbr3HBB-1xqXovaMgRomsYKKjktOddcstIyCUJIK6sSgReNRSGhYKA5aFqAMbWp-ZzcTL3bGL4GTL1qXTLo_TSxYrKiXHIh6IiyCTUxpBSxUdvoWh2_FQW1N6g2am9Q7Q2qyeAYuj70D3WL9i_yq2wE7icAxy13DqNKxu1NWBfR9MoG91__D2mUghg</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Glantschnigg-Eisl, U.</creator><creator>Klang, A.</creator><creator>Kneissl, S.</creator><creator>Lang, B.</creator><creator>Waters, P.</creator><creator>Irani, S.R.</creator><creator>Binks, S.N.M.</creator><creator>Pakozdy, A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202306</creationdate><title>A feline model of spontaneously occurring autoimmune limbic encephalitis</title><author>Glantschnigg-Eisl, U. ; Klang, A. ; Kneissl, S. ; Lang, B. ; Waters, P. ; Irani, S.R. ; Binks, S.N.M. ; Pakozdy, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-7a3b5bd2e00fffd51731633a3726d270557d796e034fde570420a30a140ccbcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Autoantibodies - therapeutic use</topic><topic>Autoimmune</topic><topic>Cat Diseases</topic><topic>Cats</topic><topic>Encephalitis</topic><topic>Encephalitis - complications</topic><topic>Encephalitis - veterinary</topic><topic>Humans</topic><topic>Leucine-rich glioma-inactivated 1 (LGI1)</topic><topic>Limbic Encephalitis - complications</topic><topic>Limbic Encephalitis - therapy</topic><topic>Limbic Encephalitis - veterinary</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Seizures - drug therapy</topic><topic>Seizures - etiology</topic><topic>Seizures - veterinary</topic><topic>Voltage-gated potassium channel (VGKC)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glantschnigg-Eisl, U.</creatorcontrib><creatorcontrib>Klang, A.</creatorcontrib><creatorcontrib>Kneissl, S.</creatorcontrib><creatorcontrib>Lang, B.</creatorcontrib><creatorcontrib>Waters, P.</creatorcontrib><creatorcontrib>Irani, S.R.</creatorcontrib><creatorcontrib>Binks, S.N.M.</creatorcontrib><creatorcontrib>Pakozdy, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The veterinary journal (1997)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glantschnigg-Eisl, U.</au><au>Klang, A.</au><au>Kneissl, S.</au><au>Lang, B.</au><au>Waters, P.</au><au>Irani, S.R.</au><au>Binks, S.N.M.</au><au>Pakozdy, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A feline model of spontaneously occurring autoimmune limbic encephalitis</atitle><jtitle>The veterinary journal (1997)</jtitle><addtitle>Vet J</addtitle><date>2023-06</date><risdate>2023</risdate><volume>296-297</volume><spage>105974</spage><epage>105974</epage><pages>105974-105974</pages><artnum>105974</artnum><issn>1090-0233</issn><eissn>1532-2971</eissn><abstract>Autoimmune encephalitis (AE) is an important cause of encephalitis in humans and occurs at a similar rate to infectious encephalitis. It is frequently associated with antibodies against the extracellular domain of neuronal proteins. Among human AE, that with antibodies against leucine-rich glioma-inactivated 1 (LGI1) is one of the most prevalent forms, and was recently described in cats with limbic encephalitis (LE). In this study, we describe a large cohort (n = 32) of cats with AE, tested positive for voltage gated potassium channel (VGKC)-antibodies, of which 26 (81%) harboured LGI1-antibodies. We delineate their clinical and paraclinical features as well as long-term outcomes up to 5 years. Similar to human cases, most cats with LGI1-antibodies had a history of focal seizures (83%), clustering in the majority (88%), with interictal behavioural changes (73%). Among feline AE patients, there was no seizure type or other clinical characteristic that could distinguish LGI1-antibody positive from negative cats, unlike the pathognomic faciobrachial dystonic seizures seen in humans. Although six cats were euthanased in the first year for epilepsy-associated reasons, those attaining at least 1-year survival had good seizure control and quality of life with appropriate veterinary care and medication. Acute-phase immunotherapy (prednisolone) was given to the most severely unwell cases and its effect is retrospectively evaluated in 10 cats. Our data show LGI1-antibodies are an important cause of feline encephalitis, sharing many features with human AE. Further research should examine optimal therapeutic management strategies and the cause of LE in seronegative cats, building on paradigms established in the counterpart human disease. •Antibodies against leucine-rich glioma-inactivated 1 (LGI1) were studied.•They were associated with epileptic seizures and limbic encephalitis (LE) in cats.•Feline LE presented with focal seizures, often clustering, and behavioural changes.•Blood and cerebrospinal fluid analysis and brain imaging was often unremarkable.•Some cats were refractory to treatment but others attained good long-term outcomes.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36958405</pmid><doi>10.1016/j.tvjl.2023.105974</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1090-0233
ispartof The veterinary journal (1997), 2023-06, Vol.296-297, p.105974-105974, Article 105974
issn 1090-0233
1532-2971
language eng
recordid cdi_proquest_miscellaneous_2791373551
source ScienceDirect Freedom Collection
subjects Animals
Antibodies
Autoantibodies - therapeutic use
Autoimmune
Cat Diseases
Cats
Encephalitis
Encephalitis - complications
Encephalitis - veterinary
Humans
Leucine-rich glioma-inactivated 1 (LGI1)
Limbic Encephalitis - complications
Limbic Encephalitis - therapy
Limbic Encephalitis - veterinary
Quality of Life
Retrospective Studies
Seizures - drug therapy
Seizures - etiology
Seizures - veterinary
Voltage-gated potassium channel (VGKC)
title A feline model of spontaneously occurring autoimmune limbic encephalitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A56%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20feline%20model%20of%20spontaneously%20occurring%20autoimmune%20limbic%20encephalitis&rft.jtitle=The%20veterinary%20journal%20(1997)&rft.au=Glantschnigg-Eisl,%20U.&rft.date=2023-06&rft.volume=296-297&rft.spage=105974&rft.epage=105974&rft.pages=105974-105974&rft.artnum=105974&rft.issn=1090-0233&rft.eissn=1532-2971&rft_id=info:doi/10.1016/j.tvjl.2023.105974&rft_dat=%3Cproquest_cross%3E2791373551%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c351t-7a3b5bd2e00fffd51731633a3726d270557d796e034fde570420a30a140ccbcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791373551&rft_id=info:pmid/36958405&rfr_iscdi=true